ARDS (Acute Respiratory Distress Syndrome) — Acute respiratory distress syndrome (ARDS) pathophysiology (intro) - Pathophysiology

SECTION 1

Historical Context & Motivation

For much of modern medical history, clinicians observed that patients suffering from severe trauma, sepsis, or massive transfusion could rapidly develop refractory hypoxemia, bilateral pulmonary infiltrates, and stiff, non-compliant lungs — yet they lacked a unifying framework to explain this devastating presentation. The recognition that a common pathological cascade, diffuse alveolar damage (DAD), underlies these clinical features led to the formal description of what we now call acute respiratory distress syndrome (ARDS). Understanding the history behind ARDS is essential because each milestone refined our diagnostic criteria, guided ventilatory strategies, and ultimately improved survival rates from roughly 70% mortality down to approximately 30–40% in contemporary practice.

1967 • Ashbaugh & Petty Description

Ashbaugh, Bigelow, Petty, and Levine published the landmark case series of 12 patients in The Lancet, describing acute onset of tachypnea, refractory hypoxemia, decreased lung compliance, and diffuse bilateral infiltrates on chest radiography. They coined the term 'adult respiratory distress syndrome.'

1988 • Murray Lung Injury Score

Murray and colleagues proposed a lung injury scoring system incorporating PaO₂/FiO₂ ratio, PEEP level, lung compliance, and degree of radiographic infiltration, providing a semi-quantitative severity assessment.

1994 • AECC Definition

The American–European Consensus Conference (AECC) standardized the definition: acute onset, bilateral infiltrates, PaO₂/FiO₂ ≤ 200 mmHg for ARDS (≤ 300 for ALI), and absence of left atrial hypertension. The term was changed from 'adult' to 'acute' to reflect that pediatric patients are also affected.

2000 • ARDSNet ARMA Trial

The ARDS Network's landmark trial demonstrated that low tidal volume ventilation (6 mL/kg predicted body weight) reduced mortality by 22% compared to traditional volumes, establishing lung-protective ventilation as the standard of care.

2012 • Berlin Definition

The Berlin Definition replaced the AECC criteria, stratifying severity into mild (PaO₂/FiO₂ 201–300), moderate (101–200), and severe (≤ 100), all measured at a minimum PEEP of 5 cmH₂O. This classification improved prognostic validity and became the current diagnostic standard.

Despite decades of research, ARDS remains a syndrome — not a single disease — defined by its clinical presentation rather than a unique etiological agent. The central question that drives modern investigation is: How does an initial insult — whether pulmonary or extrapulmonary — trigger a stereotyped cascade of inflammation, alveolar-capillary barrier disruption, and impaired gas exchange? Answering this question is the foundation upon which rational therapeutic strategies are built.

SECTION 2

Core Principles & Definitions

ARDS is fundamentally a syndrome of acute, diffuse, inflammatory lung injury that leads to increased pulmonary vascular permeability, increased lung weight, and loss of aerated lung tissue. To understand its pathophysiology, one must first internalize several core principles that govern normal alveolar function and then appreciate how each is disrupted during the development of ARDS.

Alveolar-Capillary Barrier Integrity

The alveolar-capillary membrane consists of the capillary endothelium, a thin basement membrane, and type I alveolar epithelial cells. Normally this barrier is selectively permeable, keeping protein-rich fluid in the vasculature. In ARDS, both the endothelial and epithelial layers are damaged, allowing protein-rich edema fluid to flood the alveolar space.

Surfactant Dysfunction

Pulmonary surfactant, produced by type II pneumocytes, reduces alveolar surface tension and prevents collapse during expiration. In ARDS, surfactant is inactivated by leaked plasma proteins and its production is impaired due to type II cell injury, leading to alveolar collapse (atelectasis) and reduced compliance.

Neutrophil-Mediated Inflammation

Activated neutrophils are recruited to the pulmonary vasculature and interstitium, where they release reactive oxygen species (ROS), proteases, and pro-inflammatory cytokines (TNF-α, IL-1β, IL-8). This amplifies tissue damage beyond the initial insult.

Impaired Alveolar Fluid Clearance

Normal lungs actively reabsorb alveolar fluid via epithelial sodium channels (ENaC) and Na⁺/K⁺-ATPase pumps on type I and II cells. In ARDS, epithelial injury compromises this alveolar fluid clearance, perpetuating pulmonary edema even after vascular permeability improves.

Three Pathological Phases

ARDS progresses through the exudative phase (days 1–7), the proliferative phase (days 7–21), and potentially the fibrotic phase (after day 21). Each phase is characterized by distinct histological and physiological features.

✦

KEY TAKEAWAY

Think of the alveolar-capillary barrier like a dam holding back a reservoir. Under normal conditions, the dam (intact endothelium and epithelium) is tightly sealed, allowing only controlled amounts of water to pass through sluice gates (selective permeability). In ARDS, an inflammatory insult cracks the dam at multiple points simultaneously. Water (protein-rich edema) rushes through, flooding the valley below (alveolar spaces). At the same time, the pumps designed to remove excess water from the valley (ENaC channels, Na⁺/K⁺-ATPase) are also damaged by the same forces that cracked the dam. The result is a valley submerged in water — alveoli filled with edema fluid that cannot participate in gas exchange.

SECTION 3

Visual Explanation — Normal vs. ARDS Alveolus

Left: A normal alveolus with intact type I epithelium, functional surfactant, and an ultra-thin alveolar-capillary barrier (~0.5 µm) permitting efficient O₂/CO₂ exchange. Right: An ARDS alveolus showing damaged epithelium, protein-rich edema flooding the air space, hyaline membrane formation, neutrophil infiltration, and capillary leak — all contributing to impaired gas exchange and refractory hypoxemia.

The diagram above illustrates the fundamental contrast between healthy and injured alveoli. In the normal alveolus (left), the ultra-thin alveolar-capillary barrier — composed of type I epithelial cells, a shared basement membrane, and capillary endothelium — permits rapid diffusion of oxygen into the blood and carbon dioxide out. Surfactant, secreted by type II pneumocytes, lines the alveolar surface and prevents collapse by reducing surface tension according to the Law of Laplace. In the ARDS alveolus (right), the inflammatory cascade has disrupted both sides of the barrier. Endothelial injury increases vascular permeability, allowing protein-rich fluid and inflammatory cells — particularly neutrophils — to enter the interstitium and then the alveolar lumen. The leaked plasma proteins inactivate surfactant and polymerize into hyaline membranes, the histological hallmark of diffuse alveolar damage. These membranes further thicken the diffusion barrier, compound surfactant loss, and make the lung profoundly non-compliant.

SECTION 4

Pathophysiological Mechanisms of ARDS

The Inflammatory Cascade

The development of ARDS can be triggered by either direct pulmonary insults (pneumonia, aspiration, inhalation injury) or indirect extrapulmonary insults (sepsis, pancreatitis, massive transfusion). Regardless of the inciting cause, the downstream pathophysiological cascade converges on a stereotyped inflammatory response. The initial insult activates alveolar macrophages, which release pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-8 (IL-8). These cytokines upregulate adhesion molecules (selectins, integrins) on the pulmonary capillary endothelium, facilitating neutrophil margination, adhesion, and transmigration into the interstitial and alveolar spaces.

Endothelial and Epithelial Injury

Once recruited, neutrophils release a potent arsenal of injurious mediators. Reactive oxygen species (ROS) — including superoxide anion (O₂⁻), hydrogen peroxide (H₂O₂), and hydroxyl radicals (OH·) — directly damage cell membranes through lipid peroxidation. Proteolytic enzymes such as elastase and matrix metalloproteinases (MMPs) degrade the extracellular matrix and basement membrane. The net result is a loss of barrier function on both sides of the alveolar-capillary membrane. Endothelial gaps allow fluid and macromolecules to leak into the interstitium, while epithelial disruption allows this edema fluid to flood the alveolar lumen itself.

Consequences for Gas Exchange

Three major physiological derangements follow from alveolar flooding and collapse. First, intrapulmonary shunting occurs when blood perfuses alveoli that are completely filled with fluid or collapsed — ventilation-perfusion (V/Q) ratio approaches zero in these units, and the resulting shunt is refractory to supplemental oxygen because there is no ventilated alveolus for oxygen to reach. Second, regions of lung with partial flooding develop severely decreased V/Q mismatch, contributing further to hypoxemia. Third, the thickened alveolar-capillary barrier impairs diffusion of oxygen (though CO₂, being 20× more soluble, is less affected initially). The combination of true shunt and V/Q mismatch explains why patients with ARDS characteristically develop severe, refractory hypoxemia — the hallmark clinical feature of the syndrome.

ALVEOLAR GAS EQUATION

PAO₂ = FiO₂ × (Pᴮ − PH₂O) − (PaCO₂ / R)

Where PAO₂ = alveolar partial pressure of O₂, FiO₂ = fraction of inspired oxygen, Pᴮ = barometric pressure (≈ 760 mmHg at sea level), PH₂O = water vapor pressure (47 mmHg at 37°C), PaCO₂ = arterial CO₂, and R = respiratory quotient (≈ 0.8). The A-a gradient (PAO₂ − PaO₂) is markedly elevated in ARDS, typically > 350 mmHg on 100% O₂.

PaO₂/FiO₂ RATIO (P/F RATIO)

P/F Ratio = PaO₂ / FiO₂

The P/F ratio quantifies severity of oxygenation impairment. Normal ≈ 500 mmHg. Per the Berlin Definition: Mild ARDS: 201–300, Moderate ARDS: 101–200, Severe ARDS: ≤ 100 (all at PEEP ≥ 5 cmH₂O).

STATIC LUNG COMPLIANCE

Cₛₜₐₜ = V_T / (Pₚₗₐₜ − PEEP)

Where Cₛₜₐₜ = static compliance (normally 60–100 mL/cmH₂O), $V_T$ = tidal volume, Pₚₗₐₜ = plateau pressure, and PEEP = positive end-expiratory pressure. In ARDS, static compliance is profoundly reduced (often 20–40 mL/cmH₂O) due to alveolar flooding, atelectasis, and interstitial edema.

SECTION 5

The Three Phases of ARDS

ARDS is not a static event but a dynamic process that evolves through three overlapping histological and clinical phases. Recognizing which phase predominates at a given point in a patient's illness is critical because it informs prognosis, ventilator management, and whether the patient may benefit from specific interventions such as corticosteroids or prone positioning.

The three overlapping phases of ARDS. The exudative phase (days 1–7) is characterized by acute inflammation and alveolar flooding. The proliferative phase (days 7–21) features attempted repair with type II cell proliferation and fibroblast migration. The fibrotic phase (after day 21) occurs in a subset of patients and is marked by irreversible scarring and persistent ventilator dependence.

During the exudative phase, the dominant process is acute inflammation with massive alveolar flooding. Histologically, one observes diffuse alveolar damage with hyaline membranes, edema, hemorrhage, and necrosis of type I pneumocytes. Clinically, this manifests as acute-onset bilateral opacities on chest imaging, profound hypoxemia with a low P/F ratio, and markedly reduced lung compliance. The proliferative phase represents the lung's attempt at repair. Type II pneumocytes — the stem cells of the alveolar epithelium — proliferate and differentiate to replace destroyed type I cells. Fibroblasts and myofibroblasts begin organizing the intra-alveolar exudate, and some patients show clinical improvement. However, excessive fibroblast activity can transition into the fibrotic phase, characterized by dense collagen deposition, obliteration of normal alveolar architecture, microcyst formation, and development of pulmonary hypertension from vascular remodeling. Patients entering this phase often have prolonged ventilator dependence and significantly higher mortality.

SECTION 6

Worked Example — Assessing ARDS Severity

Consider the following clinical scenario: A 58-year-old patient is admitted to the ICU following emergency surgery for a perforated appendix complicated by fecal peritonitis. She develops progressive dyspnea and hypoxemia over the next 48 hours. Her current ventilator settings include FiO₂ of 0.70, PEEP of 10 cmH₂O, and a tidal volume of 360 mL (she has a predicted body weight of 60 kg). Her ABG shows PaO₂ of 68 mmHg and PaCO₂ of 38 mmHg. Plateau pressure is 32 cmH₂O. Chest X-ray reveals bilateral opacities not fully explained by effusions or atelectasis, and echocardiography shows normal left ventricular function.

Classifying ARDS Severity and Assessing Lung Mechanics

1
Step 1 — Verify Berlin Definition Criteria

The Berlin Definition requires four criteria: (1) Timing — respiratory symptoms must be within 1 week of a known clinical insult or new/worsening symptoms. This patient developed dyspnea within 48 hours of septic peritonitis. ✓ (2) Imaging — bilateral opacities not fully explained by effusions, lobar collapse, or nodules. CXR shows bilateral opacities meeting this criterion. ✓ (3) Origin — respiratory failure not fully explained by cardiac failure or fluid overload. Echocardiography shows normal LV function. ✓ (4) Oxygenation — must be assessed at PEEP ≥ 5 cmH₂O. The patient is on PEEP = 10. ✓

All four Berlin criteria are satisfied.
2
Step 2 — Calculate the P/F Ratio

P/F Ratio = PaO₂ / FiO₂ = 68 mmHg / 0.70 = 97.1 mmHg. According to the Berlin Definition severity strata: Mild (201–300), Moderate (101–200), Severe (≤ 100). A P/F ratio of 97.1 mmHg falls at or below 100.

P/F = 97.1 mmHg → Severe ARDS
3
Step 3 — Calculate the A-a Gradient

First, calculate PAO₂ using the alveolar gas equation: PAO₂ = FiO₂ × (Pᴮ − PH₂O) − (PaCO₂ / R) = 0.70 × (760 − 47) − (38 / 0.8) = 0.70 × 713 − 47.5 = 499.1 − 47.5 = 451.6 mmHg. Then: A-a gradient = PAO₂ − PaO₂ = 451.6 − 68 = 383.6 mmHg. Normal A-a gradient for this patient's age would be approximately (Age/4) + 4 ≈ 18.5 mmHg.

A-a gradient = 383.6 mmHg (massively elevated, indicating severe shunt/V-Q mismatch)
4
Step 4 — Calculate Static Compliance

Static compliance (Cₛₜₐₜ) = $V_T$ / (Pₚₗₐₜ − PEEP) = 360 mL / (32 − 10) cmH₂O = 360 / 22 = 16.4 mL/cmH₂O. Normal static compliance is 60–100 mL/cmH₂O. This severely reduced value reflects the combination of alveolar flooding, atelectasis, surfactant dysfunction, and interstitial edema characteristic of ARDS.

Cₛₜₐₜ = 16.4 mL/cmH₂O (severely reduced)
5
Step 5 — Verify Lung-Protective Ventilation Parameters

Current tidal volume: 360 mL. Tidal volume per predicted body weight: 360 / 60 = 6 mL/kg PBW. ARDSNet recommends 6–8 mL/kg PBW. ✓ Plateau pressure: 32 cmH₂O. ARDSNet recommends < 30 cmH₂O. ✗ This patient's plateau pressure exceeds the target. The clinical team should consider further reducing tidal volume to 4–5 mL/kg PBW (accepting permissive hypercapnia if necessary) and optimizing PEEP to recruit additional alveoli while keeping Pₚₗₐₜ < 30 cmH₂O.

$V_T$ is appropriate but Pₚₗₐₜ exceeds target; requires further optimization

SECTION 7

Direct vs. Indirect ARDS — Etiology Comparison

ARDS etiologies are traditionally divided into direct (pulmonary) and indirect (extrapulmonary) causes. Although the final common pathway — diffuse alveolar damage — is similar, the initial site of injury differs, and this distinction has implications for lung mechanics, imaging patterns, and potentially for response to certain therapies such as recruitment maneuvers and prone positioning. Understanding these differences provides the clinician with a more nuanced framework for managing individual patients.

Feature	Direct (Pulmonary) ARDS	Indirect (Extrapulmonary) ARDS
Primary site of injury	Alveolar epithelium	Pulmonary capillary endothelium
Common causes	Pneumonia, aspiration, inhalation injury, pulmonary contusion, near-drowning	Sepsis (most common), pancreatitis, massive transfusion, trauma with shock, burns
CT pattern	Asymmetric consolidation, focal dense opacities	Symmetric ground-glass opacities, diffuse pattern
Chest wall compliance	Usually normal	Often decreased (e.g., abdominal distension)
Response to PEEP	Consolidation may be less recruitable	Atelectasis more recruitable; better response to PEEP/prone
Pathological emphasis	Alveolar filling with consolidation predominant	Interstitial edema → alveolar edema; congestion predominant

Comparison of direct (pulmonary) vs. indirect (extrapulmonary) ARDS

⚕

CLINICAL NUANCE

While this distinction between direct and indirect ARDS is conceptually useful, in practice the two phenotypes overlap considerably. Think of it like two rivers (pulmonary vs. extrapulmonary insults) that eventually merge into the same ocean (diffuse alveolar damage). Knowing which river the patient entered can guide early decisions — for instance, patients with indirect ARDS from sepsis may respond better to recruitment maneuvers because their predominant pathology is compressive atelectasis rather than dense alveolar consolidation — but ultimately, the supportive care principles (lung-protective ventilation, conservative fluid management, treatment of the underlying cause) remain the same.

SECTION 8

Connections to Advanced Concepts

Understanding the introductory pathophysiology of ARDS provides the scaffolding for several advanced topics that you will encounter in critical care medicine. These include the concept of ventilator-induced lung injury (VILI), advanced ARDS phenotyping, and emerging targeted therapies. The table below previews how introductory concepts connect to these more advanced areas of study.

Introductory Concept	Advanced Extension
Alveolar-capillary barrier disruption	Biomarkers of endothelial (angiopoietin-2) and epithelial (sRAGE, SP-D) injury for sub-phenotyping and prognosis
Neutrophil-mediated inflammation	Hyper-inflammatory vs. hypo-inflammatory ARDS sub-phenotypes (Calfee et al., 2014) with differential treatment responses
Reduced lung compliance & shunt	Concept of 'baby lung' (Gattinoni) — the functional lung volume in ARDS is much smaller than anatomical, guiding tidal volume selection
Three pathological phases	Role of corticosteroids (DEXA-ARDS trial) in modulating the proliferative-to-fibrotic transition
P/F ratio severity stratification	Driving pressure (ΔP = Pₚₗₐₜ − PEEP) as a potentially superior predictor of mortality (Amato et al., 2015)

Connecting introductory ARDS pathophysiology to advanced concepts

As you advance in your understanding, you will learn that the mechanical ventilator — while life-saving — can itself perpetuate and amplify lung injury through mechanisms collectively termed ventilator-induced lung injury (VILI). These include volutrauma (overdistension of aerated regions), atelectrauma (repetitive opening and collapse of unstable alveoli), and biotrauma (mechanotransduction of injurious forces into an amplified inflammatory response). Gattinoni's concept of the 'baby lung' — the notion that only a small, variably located fraction of the total lung remains aerated and thus receives the entire tidal volume — is the conceptual basis for why low tidal volumes relative to predicted body weight protect against VILI. This foundational understanding links directly back to the compliance equation you encountered earlier: when functional lung volume is small, even a modest tidal volume generates dangerous transpulmonary pressures.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

Explain why the hypoxemia in ARDS is described as 'refractory' to supplemental oxygen. In your answer, distinguish between the contribution of true intrapulmonary shunt versus V/Q mismatch, and explain why increasing FiO₂ alone cannot correct severe shunt.

Show answer

In ARDS, alveoli that are completely flooded with edema or collapsed (atelectatic) still receive blood flow but provide zero ventilation, creating a true intrapulmonary shunt (V/Q = 0). Because no fresh gas reaches these alveoli, increasing the FiO₂ in inspired gas has no effect on the blood passing through them — there is no ventilated alveolus for the oxygen to reach. In contrast, V/Q mismatch (where alveoli are partially ventilated) can be partially corrected by increasing FiO₂, as some oxygen does reach these units. Since ARDS involves a significant proportion of true shunt (often 30–50% of cardiac output), the hypoxemia is 'refractory' — meaning it cannot be adequately corrected by supplemental oxygen alone. This is why positive pressure interventions (PEEP, recruitment maneuvers, prone positioning) are essential, as they aim to recruit collapsed alveoli and convert true shunt units back into functioning gas-exchange units.

Question 2: BASIC CALCULATION

A patient with bilateral infiltrates and normal cardiac function has a PaO₂ of 120 mmHg on FiO₂ of 0.60 with PEEP of 8 cmH₂O. Calculate the P/F ratio and classify the severity of ARDS according to the Berlin Definition.

Show answer

P/F ratio = PaO₂ / FiO₂ = 120 / 0.60 = 200 mmHg. According to the Berlin Definition, a P/F ratio of 200 mmHg at PEEP ≥ 5 cmH₂O (the patient has PEEP of 8, satisfying this requirement) falls at the upper boundary of moderate ARDS (101–200 mmHg). Note that the exact threshold of 200 is included in the moderate category (the mild category is defined as P/F 201–300). This patient therefore has moderate ARDS. The Berlin Definition also requires acute onset (within 1 week), bilateral opacities not fully explained by other causes, and exclusion of cardiogenic edema — all of which are stated in the scenario. Mortality associated with moderate ARDS is approximately 32%.

Question 3: INTERMEDIATE

A 70-kg (predicted body weight) patient with severe ARDS is ventilated with a tidal volume of 420 mL, PEEP of 12 cmH₂O, and plateau pressure of 34 cmH₂O. (a) Calculate the tidal volume in mL/kg PBW. (b) Calculate the static compliance. (c) Calculate the driving pressure. (d) State which of these values exceeds ARDSNet recommendations and what adjustments you would make.

Show answer

(a)

V_T

per PBW = 420 / 70 = 6.0 mL/kg PBW — this is within the recommended range of 6–8 mL/kg PBW. (b) Static compliance =

V_T

/ (Pₚₗₐₜ − PEEP) = 420 / (34 − 12) = 420 / 22 = 19.1 mL/cmH₂O — severely reduced (normal: 60–100 mL/cmH₂O). (c) Driving pressure (ΔP) = Pₚₗₐₜ − PEEP = 34 − 12 = 22 cmH₂O. Both the plateau pressure (target < 30 cmH₂O) and driving pressure (optimal < 15 cmH₂O per Amato et al.) exceed targets. The clinician should reduce

V_T

further toward 4–5 mL/kg PBW and accept permissive hypercapnia if needed. If hypoxemia persists despite these adjustments, prone positioning should be strongly considered given the severe ARDS classification.

Question 4: APPLIED

A patient develops ARDS secondary to bacterial pneumonia (direct ARDS) and another develops ARDS secondary to necrotizing pancreatitis with sepsis (indirect ARDS). Both have the same P/F ratio of 150 mmHg. Discuss how the underlying pathophysiology differs between these two patients in terms of the primary site of alveolar-capillary barrier injury, expected CT findings, and potential differences in response to PEEP and recruitment maneuvers.

Show answer

In the pneumonia patient (direct ARDS), the primary site of injury is the alveolar epithelium. Bacterial pathogens and the host immune response directly damage type I and type II pneumocytes, leading to alveolar consolidation. CT imaging typically shows asymmetric, focal dense opacities concentrated in affected lobes. Consolidated alveoli filled with inflammatory exudate are inherently more difficult to recruit with PEEP, as the pathology is intra-alveolar filling rather than compressive collapse. In the pancreatitis/sepsis patient (indirect ARDS), circulating inflammatory mediators damage the pulmonary capillary endothelium first, producing interstitial edema that progresses to alveolar edema and compressive atelectasis. CT shows more diffuse, symmetric ground-glass opacities. These atelectatic regions tend to be more recruitable with higher PEEP and prone positioning because the pathology is primarily related to compression and edema rather than dense consolidation. However, it is important to note that these are tendencies rather than absolutes — significant overlap exists between direct and indirect ARDS phenotypes.

Question 5: CRITICAL THINKING

The concept of the 'baby lung' (Gattinoni) posits that in ARDS, the functional aerated lung volume may be reduced to as little as 300–500 mL (compared to a normal functional residual capacity of ~2,400 mL). Using this concept and the static compliance equation, explain why a 'normal' tidal volume of 12 mL/kg PBW — which was standard practice before the ARDSNet trial — is potentially harmful in ARDS, even though it would be well-tolerated by healthy lungs. Discuss the mechanisms of volutrauma and biotrauma in your answer.

Show answer

In a healthy 70-kg individual, a tidal volume of 12 mL/kg PBW (840 mL) is distributed across approximately 2,400 mL of functional residual capacity plus the additional tidal inflation — the distending force per unit of lung tissue is modest. In ARDS, if the baby lung is only 300–500 mL, that same 840 mL tidal volume is being delivered to a lung that is functionally the size of a child's lung. This creates enormous regional transpulmonary pressures in the aerated zones, causing volutrauma — mechanical overdistension and disruption of alveolar walls. Using the compliance equation, if Cₛₜₐₜ is 20 mL/cmH₂O (typical for moderate-severe ARDS), delivering 840 mL would generate a driving pressure of 840/20 = 42 cmH₂O — far exceeding safe thresholds. Beyond direct mechanical injury, the cyclic overdistension of alveolar epithelial cells activates mechanotransduction pathways (including NF-κB) that trigger release of additional pro-inflammatory cytokines — a process termed biotrauma. This local inflammatory amplification can spill into the systemic circulation, contributing to multi-organ dysfunction syndrome (MODS). The ARDSNet trial's demonstration that reducing tidal volume to 6 mL/kg PBW (420 mL in a 70-kg patient, generating a driving pressure of 420/20 = 21 cmH₂O — still high but significantly lower) reduced mortality by 22% represents the clinical validation of the baby lung concept.

SUMMARY

ARDS Pathophysiology — Summary

Summary

Acute respiratory distress syndrome (ARDS) is a syndrome of acute, diffuse, inflammatory lung injury defined by the Berlin Definition: acute onset within one week, bilateral opacities on imaging, respiratory failure not fully explained by cardiac failure, and oxygenation impairment measured by the P/F ratio (mild 201–300, moderate 101–200, severe ≤ 100 mmHg at PEEP ≥ 5 cmH₂O). The pathophysiology centers on diffuse alveolar damage: inflammatory mediators (TNF-α, IL-1β, IL-8) activate neutrophils that release reactive oxygen species and proteases, destroying the alveolar-capillary barrier and allowing protein-rich edema to flood alveoli.

This alveolar flooding inactivates surfactant and forms hyaline membranes, producing intrapulmonary shunting and refractory hypoxemia with severely reduced static compliance. The syndrome evolves through three phases: the exudative phase (acute inflammation, days 1–7), the proliferative phase (attempted repair, days 7–21), and the fibrotic phase (irreversible scarring in a subset of patients). Etiologies are classified as direct (pulmonary) or indirect (extrapulmonary), with the former primarily injuring the epithelium and the latter the endothelium, though both converge on diffuse alveolar damage. These foundational concepts prepare you for advanced topics including ventilator-induced lung injury, ARDS sub-phenotyping, and the 'baby lung' concept.